The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models
选择性 PI3Kα 抑制剂 BYL719 作为神经内分泌肿瘤的新型治疗选择：来自多种细胞系模型的结果
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0182852
Svenja Nölting, Jakob Rentsch, Helma Freitag, Katharina Detjen, Franziska Briest, Markus Möbs, Victoria Weissmann, Britta Siegmund, Christoph J Auernhammer, Elke Tatjana Aristizabal Prada, Michael Lauseker, Ashley Grossman, Samantha Exner, Christian Fischer, Carsten Grötzinger, Jörg Schrader, Patric
